Product correctly added to cart.

discount label
Quinuclidin-4-ol
View 3D

Biosynth logo

Quinuclidin-4-ol

CAS: 26458-74-2

Ref. 3D-BBA45874

10mg
266.00 €
100mg
1,059.00 €
Estimated delivery in United States, on Friday 10 Jan 2025

Product Information

Name:
Quinuclidin-4-ol
Synonyms:
  • Quinuclidin-4-Ol
Description:

Quinuclidin-4-ol is a muscarinic receptor antagonist that has long-acting effects. It binds to muscarinic receptors and blocks the effects of acetylcholine on the central nervous system. Quinuclidin-4-ol was shown to reduce salivation in rats by acting as an antagonist at M1, M2, and M3 receptors. The onset of quinuclidin-4-ol is much slower than other muscarinic antagonists such as atropine, with a half life of 2 hours. Quinuclidin-4-ol is not a direct bronchoconstrictor but can cause bronchoconstriction through its effect on the parasympathetic nervous system. This drug also reduces airway resistance by inhibiting cholinergic activity in the lungs. Quinuclidin-4-ol has been studied for its potential use in treating Parkinson's disease and schizophrenia because it acts as a long-acting muscar

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
127.19 g/mol
Formula:
C7H13NO
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-BBA45874 Quinuclidin-4-ol

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".